Information  X 
Enter a valid email address

Angle PLC Ord 10P (AGL)

Date Time Source Announcement
16 Jul 2019 9:19 am
RNS
Holding(s) in Company
12 Jul 2019 10:22 am
RNS
Result of General Meeting anf Total Voting Rights
28 Jun 2019 1:37 pm
RNS
Notice of Preliminary Results and Webcast
  1:08 pm
RNS
Holding(s) in Company
25 Jun 2019 5:19 pm
RNS
Result of Placing
  8:02 am
RNS
Accelerated bookbuild to raise �18.0m
21 Jun 2019 7:00 am
RNS
Parsortix used to investigate immunotherapy target
05 Jun 2019 7:00 am
RNS
Completion of Ovarian Cancer Pre-Study
31 May 2019 7:00 am
RNS
Positive Results from FDA Clinical Study
26 Apr 2019 7:00 am
RNS
IMMUNE SUPPRESSOR CELLS PROMOTE METASTASIS
18 Apr 2019 7:00 am
RNS
Parsortix used in new cancer assessment technique
12 Apr 2019 7:00 am
RNS
LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM
04 Apr 2019 7:00 am
RNS
AACR 2019
11 Mar 2019 7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
07 Mar 2019 7:00 am
RNS
ENROLMENT COMPLETE FOR FDA CLINICAL STUDY
28 Feb 2019 7:00 am
RNS
FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY
25 Feb 2019 7:00 am
RNS
CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX
11 Feb 2019 7:00 am
RNS
Research into role of immune cells in cancer
31 Jan 2019 7:00 am
RNS
Interim Results
29 Jan 2019 7:00 am
RNS
NEW APPLICATION FOR PARSORTIX IN CANCER ANALYSIS
11 Jan 2019 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
10 Jan 2019 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  4:01 pm
RNS
BREAKTHROUGH CANCER RESEARCH USING PARSORTIX
09 Jan 2019 7:00 am
RNS
Notice of Results
21 Dec 2018 7:00 am
RNS
Issue of LTIP Options and Share Options
28 Nov 2018 7:00 am
RNS
LEADING US HEMATOPATHOLOGIST APPOINTED AS ADVISOR
13 Nov 2018 5:10 pm
RNS
Holding(s) in Company
05 Nov 2018 7:00 am
RNS
Acquisition of outstanding shares
02 Nov 2018 2:00 pm
RNS
Price Monitoring Extension
01 Nov 2018 7:00 am
RNS
Appointment of Dr Jan Groen as NED
30 Oct 2018 4:21 pm
RNS
Result of AGM
29 Oct 2018 7:00 am
RNS
PARSORTIX SHOWS CAPABILITY TO HARVEST FETAL CELLS
25 Oct 2018 7:00 am
RNS
Good Progress with FDA Studies
09 Oct 2018 7:00 am
RNS
Notice of AGM
28 Aug 2018 7:00 am
RNS
Parsortix shows evidence of CTCs in glioblastoma
25 Jul 2018 7:00 am
RNS
Preliminary Results for year ended 30 April 2018
24 Jul 2018 5:42 pm
RNS
EIS/VCT Advance Assurance and Total Voting Rights
18 Jul 2018 10:34 am
RNS
Result of General Meeting
02 Jul 2018 7:00 am
RNS
Notice of Preliminary Results
25 Jun 2018 6:20 pm
RNS
Results of Fundraising
  2:58 pm
RNS
Close of Accelerated Bookbuild
  7:50 am
RNS
Proposed Placing of New Ordinary Shares
04 Jun 2018 7:00 am
RNS
ENCOURAGING PROGRESS IN ANG-002 FDA CLINICAL STUDY
14 May 2018 7:00 am
RNS
Leading cancer surgeon appointed
03 May 2018 7:00 am
RNS
Angle & QIAGEN Poster
19 Apr 2018 7:00 am
RNS
Parsortix in multiple presentations at AACR
  7:00 am
RNS
Breakthrough Research with Parsortix
05 Apr 2018 7:00 am
RNS
First patient enrolled in FDA study
26 Mar 2018 4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Research Update
06 Feb 2018 7:00 am
RNS
ANGLE plc: RESEARCH GRANT FROM ABBOTT
31 Jan 2018 7:00 am
RNS
Interim Results
16 Jan 2018 7:00 am
RNS
WEBINAR:USING PARSORTIX TO TEST DRUGS ON LIVE CTCS
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t